Regal Assets Analytics

SanaCurrents holding BioCryst (BCRX) shares into December 3 PDUFA

By |2020-12-02T10:26:29-05:00December 2nd, 2020|Tags: |

The FDA will decide on December 3 whether to approve BioCryst Pharmaceuticals’ (NASDAQ:BCRX) Orladeyo (berotralstat) to treat hereditary angioedema (HAE), [...]

SanaCurrents closing out Adverum Biotechnologies (ADVM)

By |2020-11-21T11:33:39-05:00November 17th, 2020|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its phase II Optic trial testing its gene therapy drug ADVM-022 [...]

Calliditas’ Shares Soar About 35% After Hitting Catalyst

By |2020-11-09T12:00:46-05:00November 9th, 2020|Tags: |

Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial of Nefecon to treat Berger’s disease, or primary IgA Nephropathy [...]

Go to Top